ArticleJournal of immunology (Baltimore, Md. : 1950)2015

Bortezomib inhibits expression of TGF-β1, IL-10, and CXCR4, resulting in decreased survival and migration of cutaneous T cell lymphoma cells.

Tzu-Pei Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.